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Abstract In China, Kudingcha has been used for almost
2,000 years as a tea to quench thirst, remove phlegm,
refresh the mind, and improve eyesight. The group of
large-leaved Kudingcha is coveted for its potential effects
on lipid metabolism, which are attributed to the presence of
characteristic ingredients. This contribution reviews studies
from the past few decades regarding the plant character-
istics, ethnobotanical usages, chemical constituents, and
related biological activities of the large-leaved Kudingcha
(Ilex latifolia Thunb and Ilex kudingcha C.J. Tseng).
Triterpenoids, phenolic acids, flavonoids, and essential oils
are the main metabolites in the large-leaved Kudingcha,
and these ingredients protect the vascular system, regulate
lipid metabolism, and have antioxidant, hypoglycemic, and
anti-tumor effects. Moreover, large-leaved Kudingcha
shares several properties with the popular green tea and the
Yerba mate´ from South America.
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Introduction
Kudingcha is a particularly bitter-tasting tea that has been
widely used in China throughout history. It is known to
disperse wind-heat, clear toxins from the blood, and refresh
the mentalities. It has also been used to cure the common
cold, rhinitis, itching eyes, conjunctival congestion, and
headache; it is helpful for digestion and alleviating the
adverse effects of alcohol [1, 2]. Today, nearly 20 plants
from different families with similarities in appearance,
flavor, and traditional usage in different areas of China are
all named ‘‘Kudingcha’’ [3]. However, the plants most
commonly found in the markets of China can be divided
into 2 groups: one group, including species Ilex latifolia
Thunb and I. kudingcha C.J. Tseng, was named the ‘‘large-
leaved Kudingcha’’; the other group, containing the species
Ligustrum robustum (syn. Ligustrum purpurascens), was
named the ‘‘small-leaved Kudingcha.’’ The large-leaved
Kudingcha was certified to be the original Kudingcha
species and has obvious antioxidant, anti-inflammatory,
lipid metabolism, hepatoprotective, and anti-tumor activi-
ties [4–7], similar to the popular green tea (Camellia sin-
ensis) and the Yerba mate´ tea (Ilex paraguariensis) from
South America. Over the last several years, Kudingcha has
been considered as a dietetic beverage and is gaining
popularity with names like ‘‘beauty-slimming tea,’’ ‘‘lon-
gevity tea,’’ ‘‘green-golden tea,’’ and ‘‘clearing-heat tea.’’
In the current review, we present and analyze the plant
characteristics, ethnobotanical usages, phytochemistry, and
pharmacological activities of the large-leaved Kudingcha,
as well as its relationship with green tea and Yerba mate´
tea. These up-to-date research observations will be helpful
in understanding the characteristics and superiorities of this
special tea and would be applicable in developing new
products and herbal medicines in the future.
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Historical and ethnopharmacological investigation
of Kudingcha in China
In the book ‘‘Tong Jun Lu’’ (A.D. 25–225; E.
Han Dynasty), Kudingcha was described as having a bitter
flavor and reportedly kept people awake all night [8]. The
original species in ‘‘Tong Jun Lu’’ were investigated and
certified to be I. latifolia, I. kudingcha, and I. cortia [9]. At
present, I. cortia is called ‘‘Gougucha’’ and is classified
separately from Kudingcha due to its different botanical
characters, chemical ingredients, and medicinal usages
[11]. On the basis of our investigation of the literature,
plant resources, and chemical and molecular analyses
conducted since 2006, it appears that the large-leaved
Kudingcha from the genus Ilex (I. latifolia and I. kuding-
cha) is the original Kudingcha species [2, 8, 11].
The medicinal properties of Kudingcha were reported in
‘‘Ben Cao Shi Yi’’ of the Tang Dynasty,
including clearing the thirst and phlegm, resolving hy-
dropsia, refreshing the mind, and improving the eyesight. In
the encyclopedia ‘‘Ben Cao Gang Mu’’ of the
Ming Dynasty, Kudingcha was described as an effective
herb that contained no toxins and had medicinal properties
that could scatter wind-heat, refresh the mind and spirit, and
promote fluid production to quench thirst [3]. The records in
ancient books were all about the large-leaved Kudingcha
from the genus Ilex. The current application of I. latifolia is
limited to a few provinces of Eastern China. The supply and
market share are limited compared to that of I. kudingcha.
The other important group (the small-leaved Kudingcha)
from the genus Ligustrum was first reported in the book of
‘‘Guizhou Min Jian Fang Yao Ji’’ in 1958. Some investi-
gators put forward that the small-leaved Kudingcha origi-
nated from the mountains of Dalou and the river valley of
Wujiang in Guizhou province. It has been used in the
civilian Tujia ethnic group and Miao ethnic group for a
long time, so was named as one of the four famous old tea
species locally [2, 10]. No literal records have been found
in ancient books to date. The small-leaved Kudingcha (L.
robustum) was initially used because of its similarities in
plant morphology, bitter flavor, and ethnobotanical use in
folk medicine.
Plant characteristics and distribution of Kudingcha
species
Two species of the large-leaved Kudingcha from the genus
Ilex have very similar botanical appearances. Both come
from trees that are evergreen, and the primary difference
between the species is found at the base of the leaves [4].
The leaf characteristics of Kudingcha species are listed in
Table 1. The small-leaved Kudingcha from the genus
Ligustrum are shrubs or small trees, deciduous or ever-
green. The leaves are much smaller and thinner than the
large-leaved Kudingcha, and the flavor is not as bitter as,
which makes it more suitable to drink routinely [8].
According to Table 1, the essential leaf characteristics of
each species are useful to distinguish Kudingcha original
plants. While these Kudingcha species are distributed
across different locations over China, they have similar
ethnopharmacological properties (Table 2).
Secondary metabolites of large-leaved Kudingcha
Triterpenoids, phenolic acids, flavonoids, and essential oils
were isolated and identified from the large-leaved
Table 1 Leaf characteristics of the most commonly used Kudingcha [65, 66]
Leaf
characteristics
I. kudingcha I. latifolia L. robustum
Blade Oblong to oblong-elliptic Oblong or ovate oblong Lanceolate to subovate
or elliptic
Petiole 2–2.2 cm, abaxially subrounded, rugose, adaxially sulcate,
puberulent




Margin Doubly serrate or densely serrate Sparsely serrate –
Base Obtuse or cuneate Rounded or broadly cuneate Broadly cuneate or
subrounded
Apex Acute or short acuminate Short or long acuminate Long acuminate
Texture Leathery Thickly leathery Papery
Mid vein Raised and keeled abaxially, impressed and sparsely
puberulent adaxially
Impressed adaxially –
Lateral vein Evident on both surfaces Obscure abaxially, obvious adaxially –
Vein-pair 5–7 – –
Vein-angle About 50 – –
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Kudingcha. Among different types of constituents, trit-
erpenoids and polyphenols were considered to be the most
important metabolites, with various bioactivities (summa-
rized in Fig. 1).
Triterpenoids
The ursane-type triterpenoids with lactone at the position
of C20 and C28 are called a-kudinlactone (48–57, 113),
b-kudinlactone (58–69), and c-kudinlactone (74–78)
(Fig. 1), and are considered to be the most characteristic
chemicals in the Kudingcha species. The chemical analysis
showed that I. kudingcha had the highest total triterpenoid
content. The b-kudinlactone was the main type of triter-
penoid present in I. latifolia, while c-kudinlactone and
a-kudinlactone were not present in I. latifolia. At the same
time, none of these characteristic kudinosides were detec-
ted in the supposititious species I. pentagona and I. cornuta
of China, and the similar Yerba mate´ of South America
[11]. In addition, oleanane-type (1–13) and lupane-type
triterpenes (81–87) and their glycosides were also found in
I. latifolia and I. kudingcha.
Phenolic acids
Phenolic acids with antioxidant activities have been found
in recent years. The main types of phenolic acids found in
large-leaved Kudingcha were polyphenols and related
compounds [30, 32]. High-performance liquid chromatog-
raphy (HPLC) analysis showed the presence of 6 of these
derivatives, but no caffeine, in female and male leaves of
I. latifolia. However, the levels of these derivatives varied
from season to season. The current-year spring leaves
showed the highest levels of caffeic acid derivatives
(147–235 mg/g), while the current-year autumn leaves, old
spring leaves, and old autumn leaves had lower amounts of
the derivatives of 36, 24–44, and 31 mg/g, respectively.
The levels of 4-O-caffeoyl quinic acid increased 3–6 times
in current-year leaves from spring to autumn. The contents
of the caffeic acid derivatives in the female plant were
similar to those in the old leaves of the male plant. These
results suggest that the new spring leaves of I. latifolia
would be a good source for antioxidants [33].
Flavonoids
Compounds 90–92 and 119–121 were the main flavones
isolated from the large-leaved Kudingcha. They are also
the primary constituents in the popular green tea.
Essential oils and other secondary metabolites
The essential oils have been studied by using gas chro-
matography coupled to mass spectrometry (GC/MS),
which indicated the presence of alcohol, aldehyde, ketone,
ether, fatty acids, and fatty acid ester [34, 35]. Other sec-
ondary metabolites such as phytosterols and polysaccha-
rides were also isolated and identified [26, 41].
Biological activities
Regularly drinking Kudingcha as a herbal tea has a positive
role in the prevention and treatment of cardiovascular and
cerebrovascular diseases, diabetes, pharyngitis, and cancer,
particularly for the relevant troublesome conditions of arte-
riosclerosis, hypertension, dizziness, insomnia, palpitations,
and chest tightness caused by cardiovascular diseases [8].
The most important biological activity of the tea is lipid
metabolism activity. Moreover, it has antioxidant and anti-
tumor activities, and has effects on the hypoglycemic and
vascular system, similar to green tea and Yerba mate´ [2].
Lipid metabolism activity
An acyl CoA cholesteryl acyl transferase (ACAT) cata-
lyzes the intracellular esterification of cholesterol in vari-
ous tissues, and inhibitors of ACAT may serve as new
Table 2 Distribution and medical uses of the most commonly used Kudingcha
Common name Species Distribution Recorded uses [8]
Large-leaved Kudingcha I. kudingcha Guangxi, Guangdong, Hannan, Hunan Clearing pathogenic summer-heat and
detoxifying, treatment of the
dehydration and abdominal pain
I. latifolia Zhejiang, Jiangxi, Jiangsu Removing the excessive fire and noxious
heat from the lung and spleen, removing
the damp-heat pathogens in the large
intestine to eliminate the dysentery,
mental refreshing
Small-leaved Kudingcha L. robustum
(syn. L. purpurascens)
Guizhou, Yunnan, Sichuan Mental refreshing, treatment of the
pathogenic summer-heat, polydipsia and
thirst, headache, conjunctival
congestion











































































































































Fig. 1 The chemical structures of compounds isolated from the large-leaved Kudingcha
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No. Compound name Skel
eton
e
R1 R2 R3 R4 R5 Ref
1 β -amyrin A H Me Me H – [22]
2 erythrodiol A H Me CH2OH H – [22]
3 oleanolic acid A H Me COOH H – [22]
4 ilexosideXL VIII A GlcA CH2OH COOGlc H – [6]
5 ilekudinoside A (latifoloside O) A S3 Me COOGlc H – [6, 18]
6 mateglycoside D A S2 Me COOGlc H – [26]
7 latifoloside P A S2 Me COOS1 H – [18]
8 latifoloside Q A S3 Me COOS1 H – [18]
9 latifoloside B A S2 Me COOGlc OH – [15]
10 latifoloside C A S3 Me COOGlc OH – [15]
11 kudinoside N A S4 Me COOGlc OH – [19]
12 kudinoside O A S4 Me COOS1 OH – [19]
13 latifoloside H A S3 Me COOS1 OH – [17]
14 α -amyrin B H Me Me H H [22]
15 ursolic acid 3-O-acetate B acetyl COOH Me H H [22]
16 uvaol B H CH2OH Me H H [22]
17 uvaol 3-O-acetate B acetyl CH2OH Me H H [22]
18 ursolic acid B H COOH Me H H [22]
19 3β- palmitoyl-α -amyrin B CH3(CH2)14
CO
Me Me H H [16]
20 23-hydroxyursolic acid B H COOH CH2OH H H [5]
21 27-trans-p-coumaroyloxyursolic acid B H COOH Me O1 H [5]
22 27-cis-p-coumaroyloxyursolic acid B H COOH CH2OH O2 H [5]
23 ilekudinoside B B GlcA COOGlc Me H OH [6]
24 ilekudinoside D B Ara COOGlc CH2OH H OH [6]
25 ilekudinoside E (latifoloside L) B S5 COOGlc Me H OH [6, 18]
26 kudinoside H B Ara COOGlc Me H OH [14]
27 kudinoside G B S3 COOGlc Me H OH [14]
28 kudinoside L B S4 COOGlc Me H OH [19]
29 kudinoside P B S6 COOGlc CH2OH H OH [19]
30 kudinoside M B S4 COOS1 Me H OH [19]
31 latifoloside G B S3 COOS1 Me H OH [17]
32 ilekudinoside W B S2 COOS1 Me H OH [24]
33 latifoloside A B S2 COOGlc Me H OH [15]
34 latifoloside I (1) C S1 Me CH2OH OGlc H [23]
35 latifoloside J (1) C S1 Me COOH OGlc H [23]
36 cynarasaponin C C Glc A CH2OH COOGlc H H [6]
37 ilekudinoside C C Ara CH2OH COOGlc H OH [6]
38 3-β-D-glucuronopyranosyl asiatic acid 
28-O-β-D-glucopyranoside
C Glc A CH2OH COOGlc H OH [19]
Fig. 1 continued
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43 latifoloside J (2) D S2 S1 Me H Me [18]
44 latifoloside K D S5 Glc Me H CH2OH [18]
45 latifoloside C D S2 Glc Me H Me [15]
46 latifoloside D D S3 Glc Me H Me [15]
47 latifoloside F D S3 S1 Me H Me [17]
48 α -kudinlactone E H – – – – [14]
49 kudinoside D E S3 – – – – [14]
50 kudinoside E E S4 – – – – [14]
51 kudinoside J (2) E Ara – – – – [14]
52 ilekudinoside K E S1 – – – – [20]
53 ilekudinoside N E S7 – – – – [20]
54 ilekudinoside O E S10 – – – – [20]
55 ilekudinoside P E S5 – – – – [20]
56 ilekudinchoside C E S8 – – – – [27]
57 ilekudinchoside D E S2 – – – – [27]
58 β -kudinlactone F H OH H – – [14]
59 kudinoside B F S6 OH H – – [12]
60 kudinoside I (2) F Ara OH H – – [14]
61 ilekudinoside J F S7 OH H – – [6]
62 ilekudinoside Q F S1 OH H – – [20]
63 kudinoside A (ilekudinchoside A) F S3 OH H – – [12,
27]
64 kudinoside C F S4 OH H – – [12]
65 ilekudinoside I F S10 OH H – – [6]
66 ilekudinoside L F S5 OH H – – [20]
67 ilekudinoside R F S2 OH H – – [20]
68 3-O-β-D-glucopyranosyl-β-kudinlactone F Glc OH H – – [24]
69 ilekudinoside U F S3 EtO H – – [21]
70 ilekudinchoside B F S3 H MeO – – [27]
71 ilekudinchoside F F S3 H EtO – – [28]
72 ilekudinchoside G F S2 H MeO – – [28]
73 kudinoside LZ2 F S3 O – – [25]
74 kudinoside F G S3 OH H – – [14]
75 ilekudinoside H G S4 OH H – – [6]
76 ilekudinoside M G S2 OH H – – [20]
77 ilekudinoside S G S1 OH H – – [20]
78 ilekudinoside V G S3 O – – [21]
79 ilekudinoside G H S4 – – – – [6]
80 ilekudinoside T H S3 – – – – [21]
39 kudinoside I (1) D S3 S1 OH Me Me [19]
40 kudinoside J (1) D S4 Glc OH Me Me [19]
41 kudinoside K D S4 S1 OH Me Me [19]
42 latifoloside I (2) D S5 Glc Me H Me [18]
Fig. 1 continued
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types of medicines to treat arteriosclerosis and obesity.
Compounds 85, 89, 104, 114, and 20–22 isolated from
I. kudingcha showed potent inhibitory activity in the
ACAT assay. Compounds 104 (IC50 0.044 mM), 20 (IC50
0.064 mM), and 21 (IC50 0.073 mM) showed higher
inhibitory activity than the other compounds (IC50
0.154–0.468 mM) and those of lignans (IC50 25–207 mM)
isolated from Schisandra chinensis, Machilus thunbergii,
Magnolia denudate, Magnolia ovate, and the polyacetyl-
enes (IC50 42–86 mM) from Panax ginseng [5].
Seventeen triterpenoids isolated from the aqueous
extract of I. kudingcha were examined for inhibitory
85 ilekudinol C I CH2OH CH2OH H – – [5]
86 lup-20(29)-ene-3β,24-diol I CH2OH Me H – – [31]
87 betulin I Me CH2OH H – – [22]
88 13,28-epoxy-α-amyrin J H Me Me [5]
89 ilekudinol A J OH CH2 – – [5]
90 rutin K S9 OH – – – [61]
91 quercetin K OH OH – – – [61]
92 kaempferol K OH H – – – [61]
93 3-CQA (3-O-caffeoylquinic acid) L H Caffeoyl H H – [30]
94 4-CQA L H H Caffeoyl H – [30]
95 5-CQA L H H H Caffeoyl – [30]
96 3,4-diCQA L H Caffeoyl Caffeoyl H – [30]
97 3,5-diCQA L H Caffeoyl H Caffeoyl – [30]
98 4,5-diCQA L H H Caffeoyl Caffeoyl – [30]
99 4-CQA methyl ester L Me H Caffeoyl H – [30]
100 3,4-diCQA methyl ester L Me Caffeoyl Caffeoyl H – [30]
101 3,5-diCQA methyl ester L Me Caffeoyl H Caffeoyl – [30]
102 4,5-diCQA methyl ester L Me H Caffeoyl Caffeoyl – [30]
103 3,5-Di-Ο-caffeoyl epi-quinic acid butyl ester L Butyl Caffeoyl H Caffeoyl – [30]
No Compound name ref No Compound name Ref
104 ilekudinol B 5 115 ilekudinchoside E [29]
105 ilelic acid A 51 116 CA methyl ester [30]
106 ilelic acid B 51 117 caffeic acid [30]
107 latifoloside N 18 118 cis -roseoside [18]
108 latifoloside M 18 119 Epicatechin (EC) [61]
109 ilelic acid C 51 120 Epigallocatechin gallate (EGCG) [61]
110 ilelic acid D 51 121 Epicatechin gallate (ECG) [61]
111 3-palmitoyl-11-carbonyl-urs-12-ene 16 122 mannitol [31]
112 ilekudinoside F 6 123 vanillin [26]
113 kudinchagenin I 13 124 gallic acid [26]
114 ulmoidol 5 125 ferulic acid [26]
81 lupeol I Me Me H – – [22]
82 betulinic acid I Me COOH H – – [22]
83 3β-hydroxyl-lup-20(29)-24-methyl ester I COOMe Me H – – [16]
84 3β- palmitoyl-lup-20(29)-24-methyl ester I COOMe Me CH3(CH2 – – [16]
)14CO 
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activity in the ACAT assay. Compounds 4 (the inhibitory
activities were 64.3, 36.5, 15.7 % at 1.0, 0.2, 0.05 mg/mL,
respectively) and 36 (the inhibitory activities were 63.9,
29.0, 31.7 % at 1.0, 0.2, 0.05 mg/mL, respectively) showed
clear inhibitory activity [6].
A cell-based screening model using THP-1 macrophages
was initially applied to aggregate LDL (aggLDL)-induced
lipid deposition on macrophages to test the inhibitory
effects of the 12 triterpenoids from I. kudingcha.
Compounds 63, 64, 49–53, 55, and 62 inhibited the forma-
tion of foam cells and reduced intracellular total cholesterol
and triglyceride contents. The d-lactone ring in the aglycone
was indispensable to the biological activity. The OH group at
the C-12 position, the number of monosaccharides in the
sugar chain, and the presence of a terminal rhamnose residue
in the sugar chain might improve this inhibitory effect.
Moreover, compound 64 was considered as a potential
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Medium and high doses of total saponins (150 and
300 mg kg-1 day-1, respectively) from I. kudingcha
reduced the level of serum total cholesterol (TC) in ApoE-
knockout mice (30–35 %), a reduction that was similar to
the group treated with atorvastatin. It was likely that the
saponins reduced the level of TC through the inhibition of
ACAT activity. In addition, Kudingcha treatment led to
greater inhibition of malondialdehyde (MDA) activity than
atorvastatin [6, 36].
Protection of the vascular system
Various Ilex species were used in Chinese folk medicine
to treat coronary heart diseases. The mode of action was
considered to be mediated by their coronary vasodilative
effects. The water extract of I. latifolia was shown to
increase the contractility and decrease the frequency of
contraction in an isolated rat heart perfusion system. The
extract inhibited Na?/K?-ATPase activities in rat heart
sarcolemma, rat brain microsome, and a purified enzyme
from porcine cerebral cortex. It also inhibited Ca2?-
dependent ATPase at a similar dose. Following exposure
of the isolated rat heart to the extract at a dose that
produces pronounced cardiac effects, the inhibition of
Na?/K?-ATPase activity can be readily detected in the
heart [7].
The water extract of I. kudingcha was able to increase
coronary blood flow in isolated guinea pig heart and
increase cerebral blood flow in anesthetized rabbits, pro-
long the survival time of mice under hypoxia, and protect
rats from myocardial ischemia induced by pituitrin. The
effects were beneficial in the prevention and treatment of
coronary artery disease and angina pectoris [37].
Intravenous injection (0.05 g/kg) of the I. kudingcha
extract remarkably lowered the blood pressure of normal
anesthetized dogs. This hypotensive effect was also seen
when the extracts (0.75 and 0.94 g/kg, respectively) were
administered to 2-kidney, 1-clip hypertensive rats and
spontaneously hypertensive rats by gastric gavage. The
subcutaneous abdominal fatty tissue of normal and obese
rats decreased significantly when the animals were given
the extract (1.5 g/kg) by gastric gavage. The results sug-
gested that I. kudingcha had potential as a resource for the
treatment of hypertension and obesity [38].
Hypoglycemic effect
Caco-2 cells are derived from a human colon adenocarci-
noma and are used widely as a model of intestinal
absorption by epithelial cells and to study the absorption of
glucose in vitro. Glucose absorption by Caco-2 cells was
significantly inhibited by the aqueous extract of I. kud-
ingcha under both Na?-dependent conditions and Na?-free
conditions, indicating an effect on SGLT1 and GLUT
transporters. Analysis of the polyphenols in the extracts
suggested that dicaffeoylquinic acids and flavanols may be
particularly important in producing these effects. I. kud-
ingcha was the most effective compared to the other plants
tested, suggesting that it may merit evaluation in a clinical
setting [39].
The water extract of I. latifolia showed marked inhibi-
tion of hyperglycemia in the epinephrine hyperglycemia rat
model. The blood sugar levels of rats given either a low
dose or a high dose of the extract (5 or 10 g/kg, respec-
tively) were significantly reduced compared to the control
group, indicating that I. latifolia has potential as a hypo-
glycemic drug [40].
Antioxidant activity
The antioxidant activities of I. kudingcha have been eval-
uated in vitro. The crude extract (CE), as well as the 4
fractions of chloroform (CfF), ethyl acetate (EaF),
n-butanol (nBF), and water (WtF), were evaluated using
the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical-
scavenging assay, Trolox equivalent antioxidant capacity
(TEAC), and ferric ion reducing antioxidant power
(FRAP). The activities decreased in the order of
EaF [ nBF [ CE [ WtF [ CfF, according to the DPPH
and FRAP assays, with the exception of the rank order of
CfF and WtF in the TEAC assay. The extracts were cer-
tified to contain a large number of caffeoylquinic acids
(CQAs) (93–98), which contributed to the antioxidant
activity. From a health point of view, Kudingcha is a
beneficial herbal drink due to its antioxidant activity [32].
The ethyl acetate-soluble fraction of I. kudingcha, which
contained an abundance of phenolic compounds, displayed
remarkable free radical-scavenging activities against DPPH
(IC50 16.3 lg/mL),
OH (IC50 87.5 lg/mL for non-
site-specific and 27.3 lg/mL for site-specific assays) and
O2
- (IC50 1.3 lg/mL). The fraction also showed a strong
suppressive effect on rat liver mitochondrial peroxidation
(IC50 7.1 lg/mL) and significantly protected against the
oxidation of LDL mediated by either Cu2? or AAPH free
radicals (IC50 were 14 and 4.8 lg/mL, respectively) [30].
The crude polysaccharide KPS II of I. kudingcha and 2
refined polysaccharides, KPS IIIa and KPS IIIb from KPS
II, have concentration-dependent hydroxyl radical-scav-
enging activity. KPS IIIa and KPS IIIb were both com-
posed of arabinose, xylose, mannose, galactose, and
glucose, with molar ratios of 10.2:1.0:1.2:8.0:5.4 and
17.7:1.0:1.1:1.8:4.1, respectively. The scavenging capacity
of the crude polysaccharide was higher than that of the
refined polysaccharides [41].
The contents of total polyphenols and flavonoids of
I. latifolia and I. kudingcha were detected by DPPH assay,
J Nat Med (2013) 67:425–437 433
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ABTS? assay, OH-free radical-scavenging assay, reducing
power assay, and FRAP assay, and were found to be cor-
related with their antioxidant activities. It was found that
the water extract of I. kudingcha had both higher poly-
phenol content and better antioxidant performance than
that of I. latifolia [42].
Antimicrobial activity
The studies of the anti-bacterial effect of I. latifolia showed
an inhibitory effect on the growth of Streptococcus A
[minimum inhibitory concentration (MIC) 1,215 mg/mL),
Pneumococcus (MIC 25 mg/mL), Streptococcus B (MIC
25 mg/mL), Bacillus diphtheria (MIC 50 mg/mL), Bacil-
lus dysenteriae (MIC 50 mg/mL), Staphylococcus aureus
(MIC 100 mg/mL), Pseudomonas aeruginosa (MIC
100 mg/mL), Escherichia coli (MIC 100 mg/mL), and
Micrococcus catarrhalis (MIC 200 mg/mL) by the agar
dilution method in vitro. Intragastric administration can
significantly improve the survival rate of mice infected by
E. coli, B. dysenteriae, Pneumobacillus, and Streptococcus
B [43].
The crude polysaccharides of I. kudingcha were tested
against 7 bacterial and fungal strains commonly known to
cause food spoilage, and the results showed that the poly-
saccharides had more significant activities against bacteria
than fungi. The MIC against S. aureus was 5 mg/mL [44].
I. kudingcha was reported to have strong anti-bacterial
activity against S. aureus, Salmonella typhosa, and
b-hemolytic streptococci, as seen by the agar diffusion
method. It could also enhance the action of hypoxia tol-
erance, hypothermia tolerance, and sports tolerance in the
mouse, where it was shown to have anti-stress activities
[45].
Antiviral activity
The anti-HSV-1 activities of different extracts of I. kud-
ingcha were tested by cytopathogenic effect (CPE) obser-
vation and plaque reduction assay. The results showed that
the aqueous extract had a more pronounced anti-HSV-1
effect (IC50 108.24 lg/mL) and lower cytotoxicity (non-
toxic concentration 500 lg/mL) than the ethyl acetate and
methanol extract. It is suggested that the extract acts by
binding to the HSV-1 receptor and prevents the virus from
entering the cells [46].
Studies were also conducted to measure the antiviral
effects of I. kudingcha water extract against Coxsackie
virus B3 (CVB3) cytotoxicity in HeLa cells by CPE and
MTT methods. The results showed that this extract had a
significant anti-CVB3 effect in vitro, yielding TC50 values
of 45700.3 lg/mL, IC50 values of 119.18 lg/mL, and TI of
383.46 in HeLa cells [47].
Enhanced immunity
Aqueous extracts of I. latifolia were found to have bene-
ficial effects on humoral and cellular immunity. The sam-
ples enhanced the phagocyte function of macrophages in
the mouse abdominal cavity and increased the number of
plaque-forming cells (PFCs), indicating that I. latifolia had
potency as a new medicine to adjust and enhance the
immune function of an organism [48].
To further study this effect, mice were immunocom-
promised by intragastric treatment with dexamethasone
(DEX) for 7 days. The results showed that I. latifolia could
improve the phagocytic index of macrophages, and high
doses could distinctly enhance the number of PFCs and the
percentage of phagocytic macrophages [49].
Anti-tumor activity
The anti-tumor activity of the ethanol extract and the vol-
atile oils of the old leaves and fresh leaves of I. latifolia
were tested by MTT assays. The results showed that the
ethanol extract from the old leaves and the volatile oil from
the fresh leaves had the most potent anti-tumor activity. For
the ethanol extract of old leaves, the inhibition rate against
human gastric cancer cells SGC-7901 was 62.40 %. For the
volatile oil from the fresh leaves, the inhibition rates against
human lung cancer cells NCI-H460 (IC50 42.86 mg/mL)
and SGC-7901 were 93.33 and 32.44 %, respectively. The
results provided a scientific basis for the use of the tea in the
development of new anti-tumor medicines [50].
The growth inhibitory activities of compounds 105, 106,
109, 110, 21, and 22 were evaluated in MCF-7 (estrogen
receptor-positive) and MDA-MB-231 (estrogen receptor-
negative) human breast cancer cells. Compounds 105 and
106 showed a growth inhibitory effect against MCF-7 cells,
with IC50 values of 29.51 ± 3.44 and 38.49 ± 3.16 lM,
respectively. Compound 21 (IC50 4.58 ± 0.56 lM) was the
most potent among all the tested compounds, indicating
that the p-(E)-coumaroyl moiety at the C-27 position may
contribute to improving the growth inhibitory potential
when compared with the triterpene with the p-(Z)-couma-
royl moiety (22, IC50 12.65 ± 0.94 lM). All the tested
triterpenoids showed more potent growth inhibitory activ-
ity in MCF-7 cells than in MDA-MB-231 cells, implying
that their growth inhibitory activities may be partly
dependent on the status of the estrogen receptor [51].
The human nasopharyngeal carcinoma cell line NCE
was divided into groups A (treated with 40 lmol/L com-
pound 18), B (treated with DMSO 10 lL), and C (without
treatment), and the inhibition of cellular proliferation were
detected by Western blotting at 12, 24, 48, 72, 96, and
120 h after treatment. The cellular proliferation in group A
was remarkably inhibited at all time points, and the
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inhibitory rate increased from 16.3 to 96.4 %. Under an
optical microscope, the growth of NCE cells was inhibited,
and the morphology changed after treatment. The Western
blotting results showed that 18 could downregulate the
expression of ERK and Cyclin D1 in a time-dependent
manner. The data suggest that 18 could be used for treating
nasopharyngeal carcinoma by downregulating the expres-
sion of ERK and Cyclin D1 in nasopharyngeal carcinoma
cells [52]. In another study, an MTT assay was used to
detect the effect of 18 on cellular proliferation, microscopy
was used to observe cytotoxicity, and flow cytometry was
used to detect apoptosis and cell cycle inhibition. The
results showed that, within 24 h of treatment, 40 and
80 lmol/L of 18 inhibited the proliferation of NEC-2 cells
by 41.21 ± 0.25 and 94.11 ± 0.37 %, respectively. Both
doses could block more than 70 % of cells at G0/G1. After
24 h of treatment with 18 (40 lmol/L), cell atrophy
appeared, cell adhesion decreased, and some cells died
from fragmentation [64].
Protective activity in neuronal cells
I. latifolia has been used in Chinese folk medicine to treat
headaches and various inflammatory diseases. The protec-
tive activity of I. latifolia against glutamate-induced neuro-
toxicity was tested using cultured rat cortical neurons in
order to understand the mechanism of its inhibitory effect on
ischemic brain damage, and several potentially active com-
pounds were identified. The exposure of cultured cortical
neurons to 500 lM glutamate for 12 h triggered neuronal
cell death. I. latifolia (10–100 lg/mL) inhibited glutamate-
induced neuronal death, elevation of intracellular calcium
([Ca2?]i), generation of reactive oxygen species (ROS),
increase of a pro-apoptotic protein, BAX, and decrease of an
anti-apoptotic protein, BcL-2. Hypoxia-induced neuronal
cell death was also inhibited by I. latifolia. Compounds 98,
99, and 101 isolated from I. latifolia also inhibited the glu-
tamate-induced increase in [Ca2?]i, generation of ROS, the
change of apoptosis-related proteins, and neuronal and
hypoxia-induced neuronal cell deaths. The results suggested
that I. latifolia and its active compounds prevented gluta-
mate-induced neuronal cell damage by inhibiting the
increase of [Ca2?]i, generation of ROS, and, resultantly, the
apoptotic pathway. In addition, the neuroprotective effects
on ischemia-induced brain damage might be associated with
the anti-excitatory and anti-oxidative actions, and could be
attributable to these active compounds, CQAs [54].
Effect on pulmonary symptoms, including cough,
asthma, and expectoration
The effects of I. latifolia on isolated guinea pig tracheal
smooth muscle cells were evaluated by obtaining CaCl2
and histamine accumulative dose–response curves in vitro.
After incubation with the aqueous extract of I. latifolia, the
dose–response curves of CaCl2 and histamine were sig-
nificantly shifted to the right and the maximal contractile
force was reduced. The extract could inhibit the isolated
tracheal strip contraction induced by acetylcholine and
histamine (IC50 pf 0.16 and 0.21 mg/mL, respectively). It
also had a significant dilating effect on tracheal smooth
muscle, which indicated that I. latifolia had an important
effect on pulmonary symptoms [55].
Toxicity
Kudingcha has been historically consumed as a functional
tea, reflecting the philosophy of medicine–food homology
in traditional Chinese medicine, with little or no acute
toxicity. Acute and long-term toxicity of I. latifolia was
studied in rats using aqueous extracts. The maximum tol-
erable dose was 168 g/kg, indicating that there is no acute
toxicity. There were also no effects on body weight,
hematopoiesis, and biochemical index in the blood of rats
intragastrically treated with aqueous extracts at 4.5, 9, or
18 g/kg for 90 days [56].
Clinical usage
Studies have shown that drinking tea from both I. kud-
ingcha and I. latifolia for 2 months is sufficient to reduce
hypertension nearly as well as or better than common
hypertension medications such as nifedipine [57, 58]. More
importantly, no adverse reaction was observed. These
studies suggested that I. latifolia and I. kudingcha have
potential use in the treatment of hypertension.
The relationship between the large-leaved Kudingcha
and related teas
Interestingly, the large-leaved Kudingcha from the genus
Ilex has many similarities to Yerba mate´ tea (I. paragu-
ariensis) from South America and the worldwide popular
green tea (C. sinensis), a member of the Theaceae family
[59]. These 3 teas have all been historically used and have
shown antioxidant, lipid-lowering, anti-inflammatory,
weight-reducing, anti-tumor, and anti-glycation properties
[2, 5, 6]. These similarities could be ascribed to their
similar phylogeny and chemical compositions.
In order to better understand the relationship among
these teas, further comparison of the main chemical con-
stituents of the large-leaved Kudingcha and the other 2
teas have been discussed. Most notably, the common
chemical characters in regular tea are caffeine,
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polyphenols, and catechins. Caffeine, which is related to
weight reduction, is the highest in Yerba mate´ tea, med-
ium in the green tea, and could not be found in the large-
leaved Kudingcha [60, 61]. Polyphenols with conformed
antioxidant activities are also the highest in Yerba mate´
tea, followed by green tea and large-leaved Kudingcha.
The primary polyphenols in the large-leaved Kudingcha
are 3,5-di-O-caffeoylquinic acid and related dicaffeoyl-
quinic acids, whereas chlorogenic acid is the main poly-
phenol in Yerba mate´ tea. Catechins, which have
anti-tumor properties, are the highest in green tea, fol-
lowed by the large-leaved Kudingcha and Yerba mate´ tea
[32, 62, 63]. Moreover, the saponins were thought to be
the source of the bitter flavor and one of the important
characteristics in the large-leaved Kudingcha and Yerba
mate´ teas. The aroma components in Ilex and green tea
also had several similarities.
The long history, similar chemical structure, and com-
mon pharmaceutical activities suggest a close genetic
relationship among the large-leaved Kudingcha, Yerba
mate´ tea, and green tea. Although the large-leaved Kud-
ingcha is not as popular worldwide, we should pay more
attention to its possible benefits and advantages, such as the
lack of caffeine that is found in more ordinary teas.
Conclusions
A large number of phytochemical studies have led to the
identification of multiple constituents of the large-leaved
Kudingcha that confer properties such as lipid metabolism,
vascular system protection, antioxidant, anti-asthma, anti-
tussive, and anti-tumor activities. A critical assessment of
the results presented in this review may provide scientific
evidence for reasonable utilization of the original plants of
the large-leaved Kudingcha and promote further investi-
gation for the development of new herbal medicine and tea
products. More pharmacological activities need to be
undertaken and relevant mechanisms understood in order
to enhance the utilization and quality of Kudingcha species
in the future.
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